The FDA has approved a treatment option for adults with multidrug resistant HIV infection, marking a “new class of antiretroviral medications” for this patient population.
The US Food and Drug Administration approved a drug for the treatment of HIV-1 infection in conjunction with other antiretroviral therapies among children aged at least 4 weeks who weigh at least 3 kg.
...
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
After a clinical trial showed positive results in 89% of participants, a new drug regimen was approved by the FDA for highly drug-resistant forms of pulmonary tuberculosis.
The FDA has approved the first vaccine approved in the US for the prevention of dengue disease caused by all 4 serotypes of dengue virus in patients aged 9 through 16 years with laboratory-confirmed...
After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
The antibacterial drug is approved to treat travelers’ diarrhea, which is defined as having 3 or more unformed stools in 24 hours, in a person who is traveling.
